Peer Review reports
From: SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer
| Original Submission | ||
|---|---|---|
| 17 Jan 2022 | Submitted | Original manuscript |
| 27 Jan 2022 | Author responded | Author comments - Chakyung Youn |
| 28 Jan 2022 | Author responded | Author comments - Chakyung Youn |
| Resubmission - Version 2 | ||
| 27 Jan 2022 | Submitted | Manuscript version 2 |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 26 Feb 2022 | Reviewed | Reviewer Report |
| 27 Feb 2022 | Reviewed | Reviewer Report - Arnatchai Maiuthed |
| 28 Feb 2022 | Reviewed | Reviewer Report - Huiyu Li |
| 22 Mar 2022 | Author responded | Author comments - Chakyung Youn |
| Resubmission - Version 4 | ||
| 22 Mar 2022 | Submitted | Manuscript version 4 |
| 29 Mar 2022 | Author responded | Author comments - Chakyung Youn |
| Resubmission - Version 5 | ||
| 29 Mar 2022 | Submitted | Manuscript version 5 |
| 4 Apr 2022 | Author responded | Author comments - Chakyung Youn |
| Resubmission - Version 6 | ||
| 4 Apr 2022 | Submitted | Manuscript version 6 |
| 11 Apr 2022 | Reviewed | Reviewer Report - Huiyu Li |
| 17 Apr 2022 | Reviewed | Reviewer Report |
| 25 Apr 2022 | Reviewed | Reviewer Report - Arnatchai Maiuthed |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 27 Apr 2022 | Editorially accepted | |
| 16 May 2022 | Article published | 10.1186/s12885-022-09631-z |
You can find further information about peer review here.